Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6MILESTONE PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 12257224

Drug Substance Claim :

Drug Product Claim :

Application Number : 218571

Patent Use Code : U-4370

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-07-15

blank

02

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 10117848

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218571

Patent Use Code : U-4370

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-04-13

blank

03

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 10010522

Drug Substance Claim :

Drug Product Claim :

Application Number : 218571

Patent Use Code : U-38

Delist Requested :

Patent Use Description : TREATMENT OF PAROXYSMA...

Patent Expiration Date : 2028-06-19

blank

04

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 9463179

Drug Substance Claim :

Drug Product Claim :

Application Number : 218571

Patent Use Code : U-4370

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-19

blank

05

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 10010523

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218571

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-19

blank

06

MILESTONE PHARMS USA

arrow
euroPLX 90 Lisbon
Not Confirmed

MILESTONE PHARMS USA

Country
arrow
euroPLX 90 Lisbon
Not Confirmed

ETRIPAMIL

US Patent Number : 9227918

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218571

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-19

blank